Rebaum’s generic name is Eloxacinumab Injection, and the interval between injections can be delayed, with the delay continuing the previous dosing schedule for one week, and rescheduling for more than one week. Eloxacinumab Injection is used for the treatment of hypercholesterolemia, atherosclerotic cardiovascular disease in adults. The interval between injections of this product is able to be delayed, if the delayed injection is not more than a week, you can continue the previous dosing schedule, if the interval between injections is more than a week, to start from the time of this dosing, re-planning the dosing schedule. Adverse reactions to this product commonly include rash, respiratory infections, pain and bruising at the injection site. Contraindications are prohibited for those who are allergic to it. Note that if a severe anaphylactic reaction occurs after administration of the drug, treatment should be promptly discontinued and monitored until it resolves. Eloxacinumab injection should be applied under the guidance of a physician, and should not be used on its own to avoid adverse consequences.